Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)

Ilan Zaffran, Nadine Landolina, Pratibha Gaur, Tihana Lenac Rovis, Stipan Jonjic, Ofer Mandelboim, Bernhard B. Singer, Francesca Levi-Schaffer*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

In this article the author name Stipan Jonjic was incorrectly written as Jonjic Stipan. The original article has been corrected.

Original languageAmerican English
Pages (from-to)926
Number of pages1
JournalCancer Gene Therapy
Volume30
Issue number6
DOIs
StatePublished - Jun 2023

Bibliographical note

Publisher Copyright:
© 2023 The Author(s), under exclusive licence to Springer Nature America, Inc.

Fingerprint

Dive into the research topics of 'Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)'. Together they form a unique fingerprint.

Cite this